Check Out What Whales Are Doing With ABBV
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on AbbVie (NYSE:ABBV), with 60% of recent trades being bearish and 40% bullish. The total amount for put options is $239,135 and for call options is $139,784. Whales have been targeting a price range from $65.0 to $160.0 for AbbVie over the last 3 months. Raymond James has downgraded its action to Outperform with a price target of $177.
October 03, 2023 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bearish stance taken by a significant investor on AbbVie. 60% of recent trades are bearish. Raymond James downgrades to Outperform with a $177 target.
The bearish stance taken by a significant investor, along with the higher volume of put options, indicates a potential short-term downward pressure on AbbVie's stock. Additionally, the downgrade by Raymond James, despite the higher price target, could also negatively impact the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100